Loading…

The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica

The effect of the active sulphoxide metabolite of the anthelmintic triclabendazole (TCBZ-SX, 15–50 μg ml −1) on the incorporation of radioactively labelled [ 14C] leucine by adult Fasciola hepatica tissue slices was measured by liquid scintillation counting. In addition, the ability of the microfila...

Full description

Saved in:
Bibliographic Details
Published in:International journal for parasitology 1995-04, Vol.25 (4), p.421-429
Main Authors: Stitt, A.W., Fairweather, I., Mackender, R.O.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83
cites cdi_FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83
container_end_page 429
container_issue 4
container_start_page 421
container_title International journal for parasitology
container_volume 25
creator Stitt, A.W.
Fairweather, I.
Mackender, R.O.
description The effect of the active sulphoxide metabolite of the anthelmintic triclabendazole (TCBZ-SX, 15–50 μg ml −1) on the incorporation of radioactively labelled [ 14C] leucine by adult Fasciola hepatica tissue slices was measured by liquid scintillation counting. In addition, the ability of the microfilament-disrupting drug, cytochalasin B, and the microtubule-disrupting drug, tubulozole-C, to inhibit protein synthesis, was assessed by similar methods and compared with TCBZ-SX. The established protein synthesis inhibitors, cycloheximide and actinomycin D were used as positive controls. All the drugs showed a significant inhibition of protein synthesis, albeit to different extents; however, TCBZ-SX was the most potent, with no significant difference between its effect and that of cycloheximide or actinomycin D. Moreover, the concentration of TCBZ-SX, above 15 μg ml −1, had little further influence on incorporation of [ 14C] leucine. This investigation demonstrates the inhibitory effect of TCBZ-SX, cytochalasin B and tubulozole-C on protein synthesis in F. hepatica and confirms the qualitative observations made in several previous ultrastructural studies
doi_str_mv 10.1016/0020-7519(94)00140-J
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77449701</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>002075199400140J</els_id><sourcerecordid>77449701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83</originalsourceid><addsrcrecordid>eNp9kc9KJDEQh4PsouPoGyjksIiC7SadpJO-CIv4Z0XYi3sO6XSFiWa6x6RHdjz5IPpyPokZZ5jjnqqgvl9RfIXQASVnlNDqJyElKaSg9XHNTwihnBS3W2hElawLQpn4hkYbZAftpvSQIcE430bbsmKionKEJvcTwOAc2AH3Dg_R22Aa6Frz0gfAxx-vb1cm-Q7-fby-n-C-w7PYD-A7nBbdMIHkE24WOHc4-GeI2IX5I5ziHLK-DwZPYGYGb80e-u5MSLC_rmP09-ry_uKmuPtz_fvi111hmaqGwhLJHFOmNMSCJIrV1inGQYFqqGlVo8C11hHCJBMlawSQCihrSyihFVaxMTpa7c13Ps0hDXrqk4UQTAf9PGkpOa9l9jNGfAXa2KcUwelZ9FMTF5oSvRSsl_b00p6uuf4SrG9z7HC9f95Mod2E1kbz_Md6ng2Y4KLprE8bjAmqBOcZO19hkF08e4g6-4LOQutj_oVue___Oz4B1PyZTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77449701</pqid></control><display><type>article</type><title>The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica</title><source>ScienceDirect Journals</source><creator>Stitt, A.W. ; Fairweather, I. ; Mackender, R.O.</creator><creatorcontrib>Stitt, A.W. ; Fairweather, I. ; Mackender, R.O.</creatorcontrib><description>The effect of the active sulphoxide metabolite of the anthelmintic triclabendazole (TCBZ-SX, 15–50 μg ml −1) on the incorporation of radioactively labelled [ 14C] leucine by adult Fasciola hepatica tissue slices was measured by liquid scintillation counting. In addition, the ability of the microfilament-disrupting drug, cytochalasin B, and the microtubule-disrupting drug, tubulozole-C, to inhibit protein synthesis, was assessed by similar methods and compared with TCBZ-SX. The established protein synthesis inhibitors, cycloheximide and actinomycin D were used as positive controls. All the drugs showed a significant inhibition of protein synthesis, albeit to different extents; however, TCBZ-SX was the most potent, with no significant difference between its effect and that of cycloheximide or actinomycin D. Moreover, the concentration of TCBZ-SX, above 15 μg ml −1, had little further influence on incorporation of [ 14C] leucine. This investigation demonstrates the inhibitory effect of TCBZ-SX, cytochalasin B and tubulozole-C on protein synthesis in F. hepatica and confirms the qualitative observations made in several previous ultrastructural studies</description><identifier>ISSN: 0020-7519</identifier><identifier>EISSN: 1879-0135</identifier><identifier>DOI: 10.1016/0020-7519(94)00140-J</identifier><identifier>PMID: 7635617</identifier><identifier>CODEN: IJPYBT</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>actinomycin D ; Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiparasitic agents ; Benzimidazoles - pharmacology ; Biological and medical sciences ; cycloheximide ; cytochalasin B ; Cytochalasin B - pharmacology ; Digenea ; Dioxolanes - pharmacology ; Fasciola hepatica ; Fasciola hepatica - drug effects ; Fasciola hepatica - metabolism ; fluke ; Leucine - pharmacokinetics ; liquid scintillation counting ; Male ; Medical sciences ; Pharmacology. Drug treatments ; protein synthesis ; Protein Synthesis Inhibitors - pharmacology ; Rats ; Rats, Wistar ; sulphoxide metabolite of triclabendazole (TCBZ-SX) ; Trematoda ; Triclabendazole ; tubulozole-C</subject><ispartof>International journal for parasitology, 1995-04, Vol.25 (4), p.421-429</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83</citedby><cites>FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3518544$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7635617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stitt, A.W.</creatorcontrib><creatorcontrib>Fairweather, I.</creatorcontrib><creatorcontrib>Mackender, R.O.</creatorcontrib><title>The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica</title><title>International journal for parasitology</title><addtitle>Int J Parasitol</addtitle><description>The effect of the active sulphoxide metabolite of the anthelmintic triclabendazole (TCBZ-SX, 15–50 μg ml −1) on the incorporation of radioactively labelled [ 14C] leucine by adult Fasciola hepatica tissue slices was measured by liquid scintillation counting. In addition, the ability of the microfilament-disrupting drug, cytochalasin B, and the microtubule-disrupting drug, tubulozole-C, to inhibit protein synthesis, was assessed by similar methods and compared with TCBZ-SX. The established protein synthesis inhibitors, cycloheximide and actinomycin D were used as positive controls. All the drugs showed a significant inhibition of protein synthesis, albeit to different extents; however, TCBZ-SX was the most potent, with no significant difference between its effect and that of cycloheximide or actinomycin D. Moreover, the concentration of TCBZ-SX, above 15 μg ml −1, had little further influence on incorporation of [ 14C] leucine. This investigation demonstrates the inhibitory effect of TCBZ-SX, cytochalasin B and tubulozole-C on protein synthesis in F. hepatica and confirms the qualitative observations made in several previous ultrastructural studies</description><subject>actinomycin D</subject><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiparasitic agents</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>cycloheximide</subject><subject>cytochalasin B</subject><subject>Cytochalasin B - pharmacology</subject><subject>Digenea</subject><subject>Dioxolanes - pharmacology</subject><subject>Fasciola hepatica</subject><subject>Fasciola hepatica - drug effects</subject><subject>Fasciola hepatica - metabolism</subject><subject>fluke</subject><subject>Leucine - pharmacokinetics</subject><subject>liquid scintillation counting</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>protein synthesis</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>sulphoxide metabolite of triclabendazole (TCBZ-SX)</subject><subject>Trematoda</subject><subject>Triclabendazole</subject><subject>tubulozole-C</subject><issn>0020-7519</issn><issn>1879-0135</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNp9kc9KJDEQh4PsouPoGyjksIiC7SadpJO-CIv4Z0XYi3sO6XSFiWa6x6RHdjz5IPpyPokZZ5jjnqqgvl9RfIXQASVnlNDqJyElKaSg9XHNTwihnBS3W2hElawLQpn4hkYbZAftpvSQIcE430bbsmKionKEJvcTwOAc2AH3Dg_R22Aa6Frz0gfAxx-vb1cm-Q7-fby-n-C-w7PYD-A7nBbdMIHkE24WOHc4-GeI2IX5I5ziHLK-DwZPYGYGb80e-u5MSLC_rmP09-ry_uKmuPtz_fvi111hmaqGwhLJHFOmNMSCJIrV1inGQYFqqGlVo8C11hHCJBMlawSQCihrSyihFVaxMTpa7c13Ps0hDXrqk4UQTAf9PGkpOa9l9jNGfAXa2KcUwelZ9FMTF5oSvRSsl_b00p6uuf4SrG9z7HC9f95Mod2E1kbz_Md6ng2Y4KLprE8bjAmqBOcZO19hkF08e4g6-4LOQutj_oVue___Oz4B1PyZTg</recordid><startdate>19950401</startdate><enddate>19950401</enddate><creator>Stitt, A.W.</creator><creator>Fairweather, I.</creator><creator>Mackender, R.O.</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950401</creationdate><title>The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica</title><author>Stitt, A.W. ; Fairweather, I. ; Mackender, R.O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>actinomycin D</topic><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiparasitic agents</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>cycloheximide</topic><topic>cytochalasin B</topic><topic>Cytochalasin B - pharmacology</topic><topic>Digenea</topic><topic>Dioxolanes - pharmacology</topic><topic>Fasciola hepatica</topic><topic>Fasciola hepatica - drug effects</topic><topic>Fasciola hepatica - metabolism</topic><topic>fluke</topic><topic>Leucine - pharmacokinetics</topic><topic>liquid scintillation counting</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>protein synthesis</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>sulphoxide metabolite of triclabendazole (TCBZ-SX)</topic><topic>Trematoda</topic><topic>Triclabendazole</topic><topic>tubulozole-C</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stitt, A.W.</creatorcontrib><creatorcontrib>Fairweather, I.</creatorcontrib><creatorcontrib>Mackender, R.O.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal for parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stitt, A.W.</au><au>Fairweather, I.</au><au>Mackender, R.O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica</atitle><jtitle>International journal for parasitology</jtitle><addtitle>Int J Parasitol</addtitle><date>1995-04-01</date><risdate>1995</risdate><volume>25</volume><issue>4</issue><spage>421</spage><epage>429</epage><pages>421-429</pages><issn>0020-7519</issn><eissn>1879-0135</eissn><coden>IJPYBT</coden><abstract>The effect of the active sulphoxide metabolite of the anthelmintic triclabendazole (TCBZ-SX, 15–50 μg ml −1) on the incorporation of radioactively labelled [ 14C] leucine by adult Fasciola hepatica tissue slices was measured by liquid scintillation counting. In addition, the ability of the microfilament-disrupting drug, cytochalasin B, and the microtubule-disrupting drug, tubulozole-C, to inhibit protein synthesis, was assessed by similar methods and compared with TCBZ-SX. The established protein synthesis inhibitors, cycloheximide and actinomycin D were used as positive controls. All the drugs showed a significant inhibition of protein synthesis, albeit to different extents; however, TCBZ-SX was the most potent, with no significant difference between its effect and that of cycloheximide or actinomycin D. Moreover, the concentration of TCBZ-SX, above 15 μg ml −1, had little further influence on incorporation of [ 14C] leucine. This investigation demonstrates the inhibitory effect of TCBZ-SX, cytochalasin B and tubulozole-C on protein synthesis in F. hepatica and confirms the qualitative observations made in several previous ultrastructural studies</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>7635617</pmid><doi>10.1016/0020-7519(94)00140-J</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-7519
ispartof International journal for parasitology, 1995-04, Vol.25 (4), p.421-429
issn 0020-7519
1879-0135
language eng
recordid cdi_proquest_miscellaneous_77449701
source ScienceDirect Journals
subjects actinomycin D
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiparasitic agents
Benzimidazoles - pharmacology
Biological and medical sciences
cycloheximide
cytochalasin B
Cytochalasin B - pharmacology
Digenea
Dioxolanes - pharmacology
Fasciola hepatica
Fasciola hepatica - drug effects
Fasciola hepatica - metabolism
fluke
Leucine - pharmacokinetics
liquid scintillation counting
Male
Medical sciences
Pharmacology. Drug treatments
protein synthesis
Protein Synthesis Inhibitors - pharmacology
Rats
Rats, Wistar
sulphoxide metabolite of triclabendazole (TCBZ-SX)
Trematoda
Triclabendazole
tubulozole-C
title The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A06%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20triclabendazole%20(%E2%80%9CFasinex%E2%80%9D)%20on%20protein%20synthesis%20by%20the%20liver%20fluke,%20Fasciola%20hepatica&rft.jtitle=International%20journal%20for%20parasitology&rft.au=Stitt,%20A.W.&rft.date=1995-04-01&rft.volume=25&rft.issue=4&rft.spage=421&rft.epage=429&rft.pages=421-429&rft.issn=0020-7519&rft.eissn=1879-0135&rft.coden=IJPYBT&rft_id=info:doi/10.1016/0020-7519(94)00140-J&rft_dat=%3Cproquest_cross%3E77449701%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c386t-c073f38a2a0ce70839cf834e8e8b1ad8b8efdcf00373523b5e06e13d2e2ed5c83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77449701&rft_id=info:pmid/7635617&rfr_iscdi=true